Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Silence Therapeutics plc | Chief Financial Officer | Employee Share Option (Right to Buy) | 375K | Jan 2, 2025 | Direct | ||
Silence Therapeutics plc | Chief Financial Officer | Ordinary Shares | 1.5K | Jan 2, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SLN | Silence Therapeutics plc | Jan 2, 2025 | 1 | $0 | 4 | Jan 6, 2025 | Chief Financial Officer |
SLN | Silence Therapeutics plc | Jan 2, 2025 | 0 | $0 | 3 | Jan 2, 2025 | Chief Financial Officer |